Challenges from Variation across Regions in Cost Effectiveness Analysis in Multi-Regional Clinical Trials. - Wikidata - wikimedia - TriplyDB

Challenges from Variation across Regions in Cost Effectiveness Analysis in Multi-Regional Clinical Trials.

Challenges from Variation across Regions in Cost Effectiveness Analysis in Multi-Regional Clinical Trials.

http://www.wikidata.org/entity/Q37373007

about

Challenges from Variation across Regions in Cost Effectiveness Analysis in Multi-Regional Clinical Trials.

http://www.wikidata.org/entity/Q37373007

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Challenges from Variation acro ...... ulti-Regional Clinical Trials.

@en

Challenges from Variation acro ...... ulti-Regional Clinical Trials.

@nl

type

label

Challenges from Variation acro ...... ulti-Regional Clinical Trials.

@en

Challenges from Variation acro ...... ulti-Regional Clinical Trials.

@nl

prefLabel

Challenges from Variation acro ...... ulti-Regional Clinical Trials.

@en

Challenges from Variation acro ...... ulti-Regional Clinical Trials.

@nl

P1433

Q37373007-E5C6E749-96D6-4CC6-B735-1534B66899E9

P1476

Q37373007-72050432-C681-467A-A423-6FE4CAB87870

P2093

Q37373007-0189D2BE-DFD5-4B88-90C7-DC2F39EDEE6E

Q37373007-58C1E202-7C5C-425B-89CF-34991EEFF9E1

Q37373007-92C39630-4A21-4654-AFAC-A50332815892

Q37373007-9DE2DAFD-D4DF-42D5-8E9B-351AD2A38BED

Q37373007-AD422DF9-D495-43CA-8B5C-289381CC5453

Q37373007-DEEB3774-08FB-4E90-A5DC-08E3DA8A8088

Q37373007-E3D1902B-19EC-4087-9743-A09E53AF85B5

P2860

Q37373007-113D78CE-0040-4A7E-8A7F-3C43181A367B

Q37373007-286EFCF0-E316-4289-BC14-358E49EB3D59

Q37373007-3087FED4-2722-4A4C-B0C7-59602C0A33DA

Q37373007-613344C5-39B1-4457-9726-51BAA1FB8C04

Q37373007-75D5BCFF-E546-420F-B402-D73B00DFD0BF

Q37373007-81129D38-9EEF-42E8-B45C-05F1207AEC22

Q37373007-9E9174F0-407C-4826-8419-D2D7BF9CEEC6

Q37373007-A8A37935-5A94-4A73-8FE2-E875F8DB88B1

Q37373007-AEC08006-E6E9-4B22-8919-DB4799848B90

Q37373007-CA285213-7002-4EDA-847C-4A4115ECBC7F

P304

Q37373007-EE146B4A-F1DC-49B8-8561-45B6D6A4B5B2

P31

Q37373007-8E6E946A-CAA7-46F1-82A8-F3BA08478316

P356

Q37373007-339E22E0-7558-4CB7-8F02-77442F63129A

P478

Q37373007-498C929C-FCCD-4897-9DAD-3D98989E2C3F

P577

Q37373007-47A37B04-E8E7-4B29-9BBE-BCB92A946AFB

P698

Q37373007-BBADF83B-7FB7-4E0D-83DE-49B2B4553DC8

P932

Q37373007-0A0AE184-1CC8-4E8E-B673-1B945FE5A5A8

P356

FPHAR.2016.00371

P1433

Frontiers in Pharmacology

P1476

Challenges from Variation acro ...... ulti-Regional Clinical Trials.

@en

P2093

Hui Huang

http://www.w3.org/2001/XMLSchema#string

Luyan Dai

http://www.w3.org/2001/XMLSchema#string

Matthew Lee Smith

http://www.w3.org/2001/XMLSchema#string

Sheng Qi

http://www.w3.org/2001/XMLSchema#string

Yang Li

http://www.w3.org/2001/XMLSchema#string

Ye Shen

http://www.w3.org/2001/XMLSchema#string

Yunbo Chu

http://www.w3.org/2001/XMLSchema#string

P2860

Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report

Dabigatran versus warfarin in patients with atrial fibrillation

What do international pharmacoeconomic guidelines say about economic data transferability?

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.

Health economic guidelines--similarities, differences and some implications.

The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments.

Conducting economic evaluations alongside multinational clinical trials: toward a research consensus.

Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis.

Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation.

Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation.

P304

371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2016.00371

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27840606

http://www.w3.org/2001/XMLSchema#string

P932

5083708

http://www.w3.org/2001/XMLSchema#string